Dr. Babar Basir: NCSI Study Overview and Objectives

Babar Basir, D.O., the co-principal-investigator for the National Cardiogenic Shock Initiative (NCSI) study, provides an overview of the study in this interview with Bobbi Chapman, M.D. Dr. Basir explains that in 2015, he and his colleagues saw that practice patterns for managing acute myocardial infarction cardiogenic shock (AMICS) were very different between institutions. “So much so that what was happening across the street at one of our friend’s hospitals in Detroit was very different than the way we were practicing, which was very different than a hospital another mile down the street was practicing.”

Dr. Basir explains that they looked at data from the cVAD registry and created a best practices protocol for managing patients with AMICS. The study began as the Detroit Cardiogenic Shock Initiative with four hospitals in Detroit, and then expanded to 80 sites throughout the country and became the National Cardiogenic Shock Initiative study. “The objective of the study,” he explains, “was to evaluate what the outcomes were when we treated patients with AMI cardiogenic shock, predominantly with Impella CP® with SmartAssist® and treated them in a protocolized fashion using cardiogenic shock teams as well.”